Fasting blood glucose for insulin adjustment with insulin glargine or NPH insulin combined with sulphonylurea in Type 2 diabetes

被引：0
|
作者：
Haupt, A
Eckert, H
Schweitzer, MA
Peiker, J
Häring, HU
Fritsche, A
机构：
[1] Aventis Pharma Deutschland GmbH, Bad Soden am Taunus, Germany
[2] Univ Tubingen, Med Klin, D-7400 Tubingen, Germany
来源：
DIABETOLOGIA | 2004年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
743
引用
收藏
页码：A269 / A269
页数：1
相关论文
共 50 条
  • [1] Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study
    H. Yki-Järvinen
    R. Kauppinen-Mäkelin
    M. Tiikkainen
    M. Vähätalo
    H. Virtamo
    K. Nikkilä
    T. Tulokas
    S. Hulme
    K. Hardy
    S. McNulty
    J. Hänninen
    H. Levänen
    S. Lahdenperä
    R. Lehtonen
    L. Ryysy
    [J]. Diabetologia, 2006, 49 : 442 - 451
  • [2] Insulin glargine or NPH combined with metformin in type 2 diabetes:: the LANMET study
    Yki-Järvinen, H
    Kauppinen-Mäkelin, R
    Tiikkainen, M
    Vähätalo, M
    Virtamo, H
    Nikkilä, K
    Tulokas, T
    Hulme, S
    Hardy, K
    McNulty, S
    Hänninen, J
    Levänen, H
    Lahdenperä, S
    Lehtonen, R
    Ryysy, L
    [J]. DIABETOLOGIA, 2006, 49 (03) : 442 - 451
  • [3] Plasma glucose profiles in patients with type 1 diabetes treated with insulin glargine or NPH insulin
    Garg, SK
    Chase, HP
    Marshall, G
    [J]. DIABETES, 2001, 50 : A435 - A436
  • [4] Reduced hypoglycemia risk with insulin glargine - A metaanalysis comparing insulin glargine with human NPH insulin in type 2 diabetes
    Rosenstock, J
    Dailey, G
    Massi-Benedetti, M
    Fritsche, A
    Lin, ZN
    Salzman, A
    [J]. DIABETES CARE, 2005, 28 (04) : 950 - 955
  • [5] Insulin glargine versus NPH insulin in patients with type 1 diabetes
    Ratner, R
    [J]. DRUGS OF TODAY, 2003, 39 (11) : 867 - 876
  • [6] Hypoglycemia and postprandial glucose are lower with insulin glargine versus NPH insulin in older type 2 diabetes patients
    Fritsche, A
    Dailey, G
    Lin, Z
    Murray, F
    Häring, H
    Rosenstock, J
    [J]. GERONTOLOGIST, 2004, 44 : 221 - 221
  • [7] Insulin glargine versus NPH insulin therapy in Asian Type 2 diabetes patients
    Pan, Chang-Yu
    Sinnassamy, Patrick
    Chung, Kab-Do
    Kim, Kwang-Won
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 76 (01) : 111 - 118
  • [8] Lower fasting blood glucose, glucose variability and nocturnal hypoglycaemia with glargine vs NPH basal insulin in subjects with Type 1 diabetes
    Bolli, G. B.
    Songini, M.
    Trovati, M.
    Del Prato, S.
    Ghirlanda, G.
    Cordera, R.
    Trevisan, R.
    Riccardi, G.
    Noacco, C.
    [J]. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2009, 19 (08) : 571 - 579
  • [9] Nocturnal glucose metabolism after a single bedtime injection of insulin glargine or NPH insulin in patients with type 2 diabetes
    Fischer, Britta
    Soydan, Nedim
    Eckhard, Michael
    Ehl, Julia
    Kunz, Clemenis
    Bretzel, Reinhard G.
    Linn, Thomas
    [J]. DIABETES, 2006, 55 : A111 - A111
  • [10] Impact of diabetes duration on hypoglycaemia in patients with type 2 diabetes treated with insulin glargine or NPH insulin
    Dailey, G. E.
    Gao, L.
    Aurand, L.
    Garg, S. K.
    [J]. DIABETES OBESITY & METABOLISM, 2013, 15 (12): : 1085 - 1092
12345